Table 1

Characteristics of study participants

SubjectsAge
(yrs)
SexFEV1pre-BD (% pred)FEV1post-BD (% pred)Change in FEV1
after BD (%)
PD20M
(mg)
ICS dosage (μg/day)Atopy status
Asthmatic subjects not on ICS
123M971025.20.03N/A+
21-160 48M728720.80.02N/A+
31-160 41M1101154.50.07N/A+
432M1141216.10.23N/A+
544M588241.10.002N/A+
61-160 22F991056.10.03N/A+
71-160 35F738212.30.08N/A
Mean358999.113.80.0331-150
Interquartile range23–4472–11082–1155.2–20.80.02–0.08
Asthmatic subjects on ICS
145M9612429.20.16200+
269M719026.80.01500+
351F9911213.10.001500+
434M9110515.40.07400+
51-160 64F9712528.90.08200
624F9811113.30.11500
761M1031084.90.631000+
850M9010011.10.011000+
923F9910340.04800+
1049M819112.30.49800+
1155M6591400.02800+
121-160 32M7695250.011000+
131-160 48M6081350.011500
1464M9811618.40.031000
151-160 49F9611115.60.031000
Mean4888104.219.50.0361-150 746.7
Interquartile range34–6176–9891–11212.3–28.90.01–0.16500–1000
Non-asthmatic controls
137M95N/DN/D6.4N/A+
222F103N/DN/DNegativeN/A+
344M8086N/DNegativeN/A+
424M117N/DN/DNegativeN/A+
51-160 23M109114N/DNegativeN/A
620M102N/DN/DNegativeN/A
721F125N/DN/DNegativeN/A
825M105100N/DNegativeN/A
91-160 21F96101N/DNegativeN/A
101-160 32M110116N/DNegativeN/A
1120M117N/DN/DNegativeN/A
Mean26105.4
Interquartile range21–3296–117
  • FEV1 = forced expiratory volume in one second; BD = bronchodilator; PD20M = dose of methacholine required to provoke a fall in FEV1 of 20% or more; ICS = inhaled corticosteroids; N/A = not applicable; N/D = not done.

  • 1-150 Geometric mean.

  • 1-160 Subjects had bronchodilator before bronchoscopy.